Back
Bunge Global SA 10K Form
Sell
46
BG
Bunge Global SA
Last Price:
$114.99
Seasonality Move:
3.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-08-09 | 10Q | BG/Bunge Global SA Quarterly |
| 2023-05-03 | 10Q | BG/Bunge Global SA Quarterly |
| 2022-10-26 | 10Q | BG/Bunge Global SA Quarterly |
| 2022-07-27 | 10Q | BG/Bunge Global SA Quarterly |
| 2022-04-27 | 10Q | BG/Bunge Global SA Quarterly |
| 2021-10-27 | 10Q | BG/Bunge Global SA Quarterly |
Receive BG News And Ratings
See the #1 stock for the next 7 days that we like better than BG
BG Financial Statistics
Sales & Book Value
| Annual Sales: | $70.3B |
|---|---|
| Cash Flow: | $828M |
| Price / Cash Flow: | 20.6 |
| Annual Sales: | $82.23 |
| Price / Book: | 1.4 |
Profitability
| EPS (TTM): | 5.43370 |
|---|---|
| Net Income (TTM): | $846M |
| Gross Margin: | $3.2B |
| Return on Equity: | 6.11% |
| Return on Assets: | 2.44% |
Bunge Global SA Earnings Forecast
Key Bunge Global SA Financial Ratios
-
The Gross Profit Margin over the past 27 years for BG is 4.51%.
-
The Selling, General & Administrative Expenses for BG have been equal to 3.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.04% of Revenue.
-
The Interest Expense is 64.07% of Operating Income.
-
The Net Earning history of BG is 1.20% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 16 years.
Bunge Global SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Food Products |
| Sector: | Consumer Staples |
| Current Symbol: | BG |
| CUSIP: | G16962 |
| Website: | bunge.com |
Debt
| Debt-to-Equity Ratio: | 1 |
|---|---|
| Current Ratio: | 1.61 |
| Quick Ratio: | 0.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.38 |
|---|---|
| Forward P/E Ratio: | 11.6 |
BG Technical Analysis vs Fundamental Analysis
Sell
46
Bunge Global SA (BG)
is a Sell
Is Bunge Global SA a Buy or a Sell?
-
Bunge Global SA stock is rated a SellThe current Bunge Global SA [BG] share price is $115.01. The Score for BG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.